Nickel 28 Files Q3 2021 Financial Statements
Repayment of Operating Debt; Initial Cash Distribution from Ramu; Strong EPS TORONTO--(BUSINESS WIRE)--$NKL #mining--Nickel 28…
4 years ago
MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular Lymphoma
– Zandelisib Demonstrated 70.3% Objective Response Rate; 35.2% Achieved Complete Response – – 9.9% of…
4 years ago
Japanese brands Yakult, Nippon Rent-A-Car, Sukiya, Natural Aqua Gel Cure and Family Mart among the winners as the 2021 World Branding Awards go Virtual
LONDON--(BUSINESS WIRE)--#worldbranding--The fourteenth edition of the World Branding Awards saw 500+ brands from more than…
4 years ago
Bango, Hilo, Kopi Kenangan, Sinarmas Land amongst the Brand of the Year winners as the 2021 World Branding Awards go Virtual
LONDON--(BUSINESS WIRE)--The fourteenth edition of the World Branding Awards saw over 500 brands from more…
4 years ago
Innisfree, Samsung Life Insurance, SK, SK Telecom and Hankook among the winners as the 2021 World Branding Awards go Virtual
LONDON--(BUSINESS WIRE)--#worldbranding--The fourteenth edition of the World Branding Awards saw over 500 brands from more…
4 years ago
2021 Indigenous Taipei Fabulous Taipei is On
ABAO and Power Station Rocking the Stage TAIPEI, TAIWAN - Media OutReach - 30 November 2021 - 2021…
4 years ago
SpeQtral closes US$8.3m funding round
SpeQtral will utilize financing proceeds to expand its commercial strategy for both satellite and terrestrial…
4 years ago
RGE Gives Sustainable Fashion a Boost with New Partnerships in Singapore
SINGAPORE - Media OutReach - 30 November 2021 - RGE has formalised two new partnerships in Singapore…
4 years ago
Vista Gold Provides Corporate Update
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (“Vista” or the “Company”) (NYSE American and TSX: VGZ) provided an…
4 years ago
Merck’s KEYTRUDA® (pembrolizumab) Approved in Japan in Combination With Chemotherapy for First-Line Treatment of Patients With Radically Unresectable, Advanced or Recurrent Esophageal Carcinoma
First Anti-PD-1/L1-Based Regimen Approved in Japan for First-Line Treatment of Advanced Esophageal Cancer KEYTRUDA Is…
4 years ago